Hinge Health, Inc. (HNGE)

Hinge Health Stock Forecast

Stock Price Forecast

The 16 analysts that cover Hinge Health stock have a consensus rating of "Strong Buy" and an average price target of $58.25, which forecasts a 26.71% increase in the stock price over the next year. The lowest target is $45 and the highest is $70.

Price Target: $58.25 (+26.71%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$45	$58.25	$59	$70
Change	-2.11%	+26.71%	+28.34%	+52.27%

Analyst Ratings

The average analyst rating for Hinge Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	5	5	5	5	6	6
Buy	9	9	9	9	10	10
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	15	15	15	17	17

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Close Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $65 → $53	Strong Buy	Maintains	$65 → $53	+15.29%	Feb 11, 2026
Rishi Jaluria RBC Capital	RBC Capital	Buy Maintains $60 → $50	Buy	Maintains	$60 → $50	+8.77%	Feb 11, 2026
Aaron Kimson Citizens	Citizens	Buy Reiterates $65	Buy	Reiterates	$65	+41.40%	Feb 11, 2026
Elizabeth Anderson Evercore ISI Group	Evercore ISI Group	Buy Maintains $65 → $50	Buy	Maintains	$65 → $50	+8.77%	Feb 11, 2026
Saket Kalia Barclays	Barclays	Buy Maintains $60 → $52	Buy	Maintains	$60 → $52	+13.12%	Feb 11, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

753.50M

Increased by 28.18%

from 587.86M

Revenue Next Year

894.00M

Increased by 18.65%

from 753.50M

EPS This Year

1.93

from -7.77

EPS Next Year

2.31

Increased by 19.68%

from 1.93

Fiscal Year	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	292.73M	390.40M	587.86M	753.50M	894.00M	1.07B	1.26B
Revenue Growth	-	33.37%	50.58%	28.18%	18.65%	19.13%	18.31%
EPS	-8.31	-0.88	-7.77	1.93	2.31	2.83	3.45
EPS Growth	-	-	-	-	19.68%	22.53%	21.78%
Forward PE	-	-	-	23.81	19.90	16.24	13.33
No. Analysts	-	-	-	19	17	7	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	782.6M	960.8M
Avg	753.5M	894.0M
Low	719.7M	832.0M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	33.1%	27.5%
Avg	28.2%	18.6%
Low	22.4%	10.4%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	2.63	3.24
Avg	1.93	2.31
Low	1.00	1.37

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	68.1%
Avg	-	19.7%
Low	-	-28.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.